Organoid Sciences

Developer of regenerative medicines for multiple diseases

placeSeongnam-si, Gyeonggi-do, South Korea calendar_todayFounded 2019 groups70 employees language organoidrx.com

Social engagement

Social engagement: 1.1K social following, 5 posts in the last 12 months — above the industry median.

Investor mix

11 investors on record; lead investors include Korea Development Bank Europe, Dongwha Pharm, Wonik Investment Partners, Time Polio Asset Management.

Investor typeCountShare
Venture capital655%
Private equity19%
Other / undisclosed436%

Recent activity

23 Jun 2026
Event
BIO International Convention 2026
16 Oct 2025
Event
KAIST 2025 ODC Community
Coming soon